Literature DB >> 11507180

Creation of killer poxvirus could have been predicted.

A Müllbacher1, M Lobigs.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11507180      PMCID： PMC115080          DOI： 10.1128/jvi.75.18.8353-8355.2001

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  17 in total

1.  Virulence of mousepox virus is independent of serpin-mediated control of cellular cytotoxicity.

Authors:  R Wallich; M M Simon; A Müllbacher
Journal:  Viral Immunol       Date:  2001       Impact factor: 2.257

2.  Enhanced cytotoxic T cell activity in IL-4-deficient mice.

Authors:  M C Villacres; C C Bergmann
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

3.  Poxvirus-encoded serpins do not prevent cytolytic T cell-mediated recovery from primary infections.

Authors:  A Müllbacher; R Wallich; R W Moyer; M M Simon
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

4.  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

Authors:  R J Jackson; A J Ramsay; C D Christensen; S Beaton; D F Hall; I A Ramshaw
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes.

Authors:  A Müllbacher; P Waring; R Tha Hla; T Tran; S Chin; T Stehle; C Museteanu; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

6.  IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo.

Authors:  S Aung; B S Graham
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

7.  Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis.

Authors:  M M Simon; P Waring; M Lobigs; A Nil; T Tran; R T Hla; S Chin; A Müllbacher
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

8.  Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo.

Authors:  S Aung; Y W Tang; B S Graham
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  Biological effects of recombinant vaccinia virus-expressed interleukin 4.

Authors:  M E Andrew; B E Coupar
Journal:  Cytokine       Date:  1992-07       Impact factor: 3.861

10.  Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.

Authors:  M Croft; L Carter; S L Swain; R W Dutton
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307
View more
  12 in total

Review 1.  Initiation of primary anti-vaccinia virus immunity in vivo.

Authors:  Matthew A Fischer; Christopher C Norbury
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection.

Authors:  Kazumoto Murata; Martin Lechmann; Ming Qiao; Toshiaki Gunji; Harvey J Alter; T Jake Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-14       Impact factor: 11.205

3.  Ethical and philosophical consideration of the dual-use dilemma in the biological sciences.

Authors:  Seumas Miller; Michael J Selgelid
Journal:  Sci Eng Ethics       Date:  2007-12-01       Impact factor: 3.525

4.  Coding ethical behaviour: the challenges of biological weapons.

Authors:  Brian Rappert
Journal:  Sci Eng Ethics       Date:  2003-10       Impact factor: 3.777

5.  Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy.

Authors:  Nanhai Chen; Clifford J Bellone; Jill Schriewer; Gelita Owens; Torgny Fredrickson; Scott Parker; R Mark L Buller
Journal:  Virology       Date:  2010-11-10       Impact factor: 3.513

Review 6.  Poxvirus tropism.

Authors:  Grant McFadden
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

7.  Information Hazards in Biotechnology.

Authors:  Gregory Lewis; Piers Millett; Anders Sandberg; Andrew Snyder-Beattie; Gigi Gronvall
Journal:  Risk Anal       Date:  2018-11-12       Impact factor: 4.000

8.  Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses.

Authors:  Debra C Quenelle; Mark N Prichard; Kathy A Keith; Dennis E Hruby; Robert Jordan; George R Painter; Alice Robertson; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.938

9.  Artificially designed pathogens - a diagnostic option for future military deployments.

Authors:  Andreas E Zautner; Wycliffe O Masanta; Rebecca Hinz; Ralf Matthias Hagen; Hagen Frickmann
Journal:  Mil Med Res       Date:  2015-07-09

10.  Why has Not There been More Research of Concern?

Authors:  Brian Rappert
Journal:  Front Public Health       Date:  2014-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.